A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19

Coronavirus update (Live): 86,321,500 cases and 1,865,798 deaths from COVID-19 virus pandemic - Worldometer. Accessed January 5, 2021. https://www.worldometers.info/coronavirus/. Ingraham, 2020, Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review, Eur Respir J, 56, 10.1183/13993003.00912-2020 Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8 Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712 Imai, 2008, The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice, Exp Physiol, 93, 543, 10.1113/expphysiol.2007.040048 Zou, 2014, Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections, Nat Commun, 5, 3594, 10.1038/ncomms4594 Schulz, 2010, CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials, BMJ, 340, c332, 10.1136/bmj.c332 CDC. Symptoms of coronavirus. Published January 4, 2021. Accessed January 5, 2021. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. 2009, Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 2019, The REDCap consortium: building an international community of software platform partners, J Biomed Inform, 95 Sica, 2005, Clinical pharmacokinetics of losartan, Clin Pharmacokinet, 44, 797, 10.2165/00003088-200544080-00003 Beigel, 2020, Remdesivir for the treatment of Covid-19 - final report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764 Biehl, 2015, Six-month quality-of-life and functional status of acute respiratory distress syndrome survivors compared to patients at risk: a population-based study, Crit Care, 19, 1, 10.1186/s13054-015-1062-y Website. Accessed January 5, 2021. https://www.jstor.org/stable/3766749?seq=1 Hinchcliff, 2011, Validity of two new patient reported outcome measures in systemic sclerosis: the PROMIS-29 profile and the FACIT-dyspnea, Arthritis Care Res, 63, 1620, 10.1002/acr.20591 Yount, 2019, Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease, J Patient Rep Outcomes, 3, 1, 10.1186/s41687-019-0155-9 Ruiz-Ortega, 2003, Modulation of angiotensin II effects, a potential novel approach to inflammatory and immune diseases, Curr Med Chem Anti-Inflamm Anti-Allergy Agents, 2, 379, 10.2174/1568014033483626 Nelson, 2020, Analytical validation of a COVID-19 qRT-PCR detection assay using a 384-well format and three extraction methods, Cold Spring Harbor Lab Core Team, 2020 Wu, 2020, Characteristics of and Important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA, 323, 1239, 10.1001/jama.2020.2648 Fleiss, 1980, A simple approximation for calculating sample sizes for comparing independent proportions, Biometrics, 36, 343, 10.2307/2529990 Horby, 2020, Dexamethasone in hospitalized patients with Covid-19 - preliminary report, N Engl J Med Asch, 2020, Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic, JAMA Intern Med, 22 2020, An EUA for bamlanivimab—a monoclonal antibody for COVID-19, JAMA Chen, 2020, SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19, N Engl J Med Weinreich, 2020, REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19, N Engl J Med, 17 Harris R. Low demand for antibody drugs against COVID-19. NPR. Published December 22, 2020. Accessed January 5, 2021. https://www.npr.org/sections/health-shots/2020/12/22/948874701/low-demand-for-antibody-drugs-against-covid-19. Lindholt M.F., Jørgensen F.J., Bor A., Petersen MB. Willingness to use an approved COVID-19 vaccine: cross-national evidence on levels and individual-level predictors. doi:10.31234/osf.io/8kn5f Wallace, 2021, Rapid transmission of severe acute respiratory syndrome coronavirus 2 in detention facility, Louisiana, USA, May-June, 2020, Emerg Infect Dis, 27, 10.3201/eid2702.204158 Jenkinson, 1997, A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?, J Public Health Med, 19, 10.1093/oxfordjournals.pubmed.a024606 [No title]. Accessed January 6, 2021. http://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Dyspnea_Scoring_Manual.pdf. Ishiyama, 2004, Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors, Hypertension, 43, 970, 10.1161/01.HYP.0000124667.34652.1a Tignanelli, 2020, Antihypertensive drugs and risk of COVID-19?, Lancet Respir Med, 8, e30, 10.1016/S2213-2600(20)30153-3 Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8 Wu, 2020, Effects of renin-angiotensin inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane protease serine 2) expression: insights Into COVID-19, Hypertension, 76, e29, 10.1161/HYPERTENSIONAHA.120.15782 Duarte M., Pelorosso F.G., Nicolosi L., et al. Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report. medRxiv. Published online August 13, 2020:2020.08.04.20167205. First randomized trial backs safety of common heart drugs in COVID-19 patients. Accessed January 5, 2021. https://www.escardio.org/The-ESC/Press-Office/Press-releases/LOPES. Mancia, 2020, Renin-angiotensin-aldosterone system blockers and the risk of Covid-19, N Engl J Med, 382, 2431, 10.1056/NEJMoa2006923 Reynolds, 2020, Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19, N Engl J Med, 382, 2441, 10.1056/NEJMoa2008975 Jaton, 2020, The use of electronic consent for COVID-19 clinical trials: lessons for emergency care research during a pandemic and beyond, Acad Emerg Med, 27, 1183, 10.1111/acem.14141 Walter, 2020, A systematic survey of randomised trials that stopped early for reasons of futility, BMC Med Res Methodol, 20, 1, 10.1186/s12874-020-0899-1